Agonistic CD40 Antibodies in Cancer Treatment by Dijana Djureinovic, Meina Wang, Harriet M. Kluger

Get full text

Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung by Dijana Djureinovic, Victor Pontén, Per Landelius, Sahar Al Sayegh, Kai Kappert, Masood Kamali-Moghaddam, Patrick Micke, Elisabeth Ståhle

Get full text

1070 ‘Decoy-resistant’ IL-18 in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma by Lin Zhang, Harriet Kluger, Lucia Jilaveanu, David A Schoenfeld, Dijana Djureinovic, Jacqueline Mann, John Huck, Aaron M Ring

Expression of cancer–testis antigens in the immune microenvironment of non‐small cell lung cancer by Feria Hikmet, Marc Rassy, Max Backman, Loren Méar, Johanna Sofia Margareta Mattsson, Dijana Djureinovic, Johan Botling, Hans Brunnström, Patrick Micke, Cecilia Lindskog

Get full text

Lenvatinib or anti-VEGF in combination with anti–PD-1 differentially augments antitumor activity in melanoma by Thuy T. Tran, Jasmine Caulfield, Lin Zhang, David Schoenfeld, Dijana Djureinovic, Veronica L. Chiang, Victor Oria, Sarah A. Weiss, Kelly Olino, Lucia B. Jilaveanu, Harriet M. Kluger

Get full text

Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma by Ruth Halaban, Kelly Olino, James Clune, David L Rimm, Harriet M Kluger, Dijana Djureinovic, Wael Ibrahim, Raymond Baumann, Anjela Galan, David G Su, David A. Schoenfeld, Raysa Cabrejo, Sajid A Khan

Get full text

Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases by Wei Wei, Michael Hurwitz, Sabina Signoretti, Lucia Jilaveanu, Toni K Choueiri, David L Rimm, Adebowale Adeniran, Sandra Martínez, Harriet M Kluger, David A Schoenfeld, Myrto Moutafi, Dijana Djureinovic, Ross D Merkin, David A Braun, Fabio Parisi

Get full text

A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better by Dijana Djureinovic, Sarah A. Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi, Lin Zhang, Ana L. Perdigoto, Wei Wei, Gail Anderson, William Damsky, Michael Hurwitz, Barbara Johnson, David Schoenfeld, Amit Mahajan, Frank Hsu, Kathryn Miller-Jensen, Yuval Kluger, Mario Sznol, Susan M. Kaech, Marcus Bosenberg, Lucia B. Jilaveanu, Harriet M. Kluger

Get full text